航天電器(002025.SZ):擬對航電系統增資3060萬元
格隆匯6月11日丨航天電器(002025.SZ)公佈,2024年6月11日,公司第七屆董事會2024年第四次臨時會議審議通過《關於對控股子公司深圳市航天電機系統有限公司同比例增資的議案》,為滿足航電系統業務發展資金需求,持續拓寬民用電機產業發展空間,促進航電系統高質量發展。經審議,董事會同意公司與關聯企業航天科工深圳(集團)有限公司(以下簡稱“深圳科工”)以現金方式同比例增資航電系統4,500萬元,其中公司對航電系統增資3,060萬元,深圳科工對航電系統增資1,440萬元,增資完成後,航電系統註冊資本由500萬元增加至5,000萬元,股東雙方出資比例保持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.